GlassScriptPhysician profile
Joan Broussard
NPI 1932258456
$422.49
in general payments reported to CMS, 2019-2025
17 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $25.60 · 2022: $70.03 · 2023: $75.32 · 2024: $124 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $56.09 | 2023-2024 | Exparel |
| Becton, Dickinson and Company | $50.42 | 2024-2025 | Phasix Mesh |
| Conmed Corporation | $33.50 | 2024 | Airseal |
| Kci USA, INC. | $28.67 | 2023 | Activ.A.C. |
| Smith+Nephew, INC. | $24.15 | 2023 | Renasys Go V2 Home, Pico |
| Astellas Pharma US INC | $23.36 | 2022 | |
| Ethicon US, LLC | $22.51 | 2022 | |
| Integra Lifesciences Corporation | $22.41 | 2025 | Integra, Surgimend, Omnigraft |
| Ucb, INC. | $22.24 | 2024 | Bimzelx |
| Abbvie INC. | $20.53 | 2024 | |
| Medtronic, INC. | $18.15 | 2025 | Emprint |
| Musculoskeletal Transplant Foundation INC. | $18.14 | 2021-2022 | |
| Kerecis Limited | $17.42 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Solventum Corporation | $16.96 | 2025 | V.A.C.Ulta, V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice |
| Getinge USA Sales, LLC | $16.53 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $16.32 | 2025 | Gore Synecor Biomaterial |
| Janssen Pharmaceuticals, INC | $15.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Broussard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.